Journal of Cardiovascular Electrophysiology

DECEMBER 7, 2023

Abstract Introduction The use of flecainide and propafenone for medical cardioversion of atrial fibrillation (AF) and atrial flutter/intra-atrial reentrant tachycardia (IART) is well-described in adults without congenital heart disease (CHD).

Congenital Heart Disease 40

Congenital Heart Disease Atrial Fibrillation Congenital Heart Disease 40

Journal of Cardiovascular Electrophysiology

DECEMBER 7, 2023

On the other hand, non-FAAM-guided ablation was performed via linear ablation, complex fractionated atrial electrogram ablation, superior vena cava isolation, and focal ablation according to the location of the non-PV foci. The primary endpoints were AF recurrence, atrial flutter, and/or atrial tachycardia.

Ablation 40

Ablation Atrial Fibrillation Atrial Flutter Tachycardia 40

Dr. Smith's ECG Blog

SEPTEMBER 7, 2020

Here is his 12-lead: There is a wide complex tachycardia with a rate of 257, with RBBB and LPFB (right axis deviation) morphology. Read about Fascicular VT here: Idiopathic Ventricular Tachycardias for the EM Physician Case Continued He was completely stable, so adenosine was administered. See Learning point 1 below. Arch Intern Med.

Tachycardia 52

Tachycardia Heart Disease Dysrhythmia Ablation 52

Journal of Cardiovascular Electrophysiology

NOVEMBER 5, 2024

Procedures were most commonly for atrial fibrillation (52.4%), atrial flutter (10.9%), and atrioventricular nodal re-entrant tachycardia (10.1%). Results 1089 patients were included: MC 718 (65.9%); Fo8 HT 105 (9.6%); Fo8 MOD 266 (24.4%). 01; minor: MC 16.5%, Fo8 HT 12.0%, Fo8 MOD 7.4%, p =.002).

Electrophysiology 40

Electrophysiology Atrial Flutter Atrial Fibrillation Tachycardia 40

Journal of Cardiovascular Electrophysiology

DECEMBER 17, 2024

Abstract Background Dofetilide is a class III antiarrhythmic agent approved for the treatment of atrial fibrillation and atrial flutter. Given the efficacy of other class III agents, it has been used off-label for the treatment of premature ventricular complexes (PVCs) and ventricular tachycardias (VTs).

Tachycardia 40

Tachycardia Heart Disease Atrial Flutter Heart Transplant 40

Dr. Smith's ECG Blog

MARCH 6, 2020

Here was his ED ECG: There is sinus tachycardia (rate about 114) with nonspecific ST-T abnormalities. There is a large peaked P-wave in lead II (right atrial enlargement) There is left axis deviation consistent with left anterior fascicular block. See my quick review of atrial tachycardia below) The tachycardia spontaneously resolved.

Heart Failure 52

Heart Failure Tachycardia Atrial Flutter Cardiomyopathy 52

DAIC

MARCH 5, 2024

2** Furthermore, the primary effectiveness endpoint (PEE) of acute pulmonary vein isolation and 12-month freedom from atrial arrhythmia recurrence (AF, Atrial Tachycardia, or Atrial Flutter) was 75.6%. iii] The study reported a low fluoroscopy time of 7.8

Ablation 59

Ablation Atrial Fibrillation Atrial Flutter Pulmonary 59

Journal of Cardiovascular Electrophysiology

DECEMBER 16, 2024

Methods The primary effectiveness endpoint (PEE) was 12-month freedom from documented atrial fibrillation/atrial flutter/atrial tachycardia plus freedom from acute procedural failure, nonstudy catheter failure, repeat ablation failure, direct current cardioversion (DCCV), and Class I/III antiarrhythmic drug (AAD) failure.

Atrial Fibrillation 40

Atrial Fibrillation Quality of Life Atrial Flutter Ablation 40

Dr. Smith's ECG Blog

DECEMBER 20, 2024

Additionally, the patient had no other apparent reason to have sinus tachycardia (such as volume depletion, bleeding, fever). So the most likely rhythm in ECG 1 is ectopic atrial tachycardia. Therefore the first part of ECG 1 shows ectopic atrial tachycardia with biventricular pacing. Point 1: What is PVARP?

Chest Pain 102

Chest Pain Tachycardia Pacemaker Defibrillator 102

Dr. Smith's ECG Blog

APRIL 8, 2015

If the patient has Abnormal Vital Signs (fever, hypotension, tachycardia, or tachypnea, or hypoxemia), then these are the primary issue to address, as there is ongoing pathology which must be identified. Electrophysiologic studies were performed in selected patients only as clinically appropriate.

Arrhythmia 52

Arrhythmia Outcomes Chest Pain Risk Factors 52

Journal of Cardiovascular Electrophysiology

JANUARY 27, 2025

Methods and Results ATA recurrence was defined as 30s recurrence of atrial fibrillation, atrial flutter or atrial tachycardia after a 90-day blanking period and through 12-months. Univariate and multivariable Cox regression analysis (with ATA recurrence as an endpoint) was performed to identify CBA responders.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Atrial Flutter Arrhythmia 40

Journal of Cardiovascular Electrophysiology

JANUARY 7, 2025

ABSTRACT Typical atrial flutter (AFL), defined as cavotricuspid isthmus (CTI)-dependent macro-re-entrant atrial tachycardia, often causes debilitating symptoms, and is associated with increased incidence of atrial fibrillation, stroke, heart failure, and death.

Atrial Flutter 45

Atrial Flutter Atrial Fibrillation Quality of Life Ablation 45